本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Avidity Biosciences, Inc.

26.66
+0.90003.49%
盘后26.660.00000.00%17:37 EDT
成交量:153.00万
成交额:4,056.76万
市值:32.05亿
市盈率:-9.23
高:27.02
开:25.77
低:25.66
收:25.76
数据加载中...
2020/12/21

重要事件披露

8-K - Current report
2020/11/10

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/11/10

重要事件披露

8-K - Current report
2020/08/11

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2020/08/10

重要事件披露

8-K - Current report
2020/07/27

重要事件披露

8-K - Current report
2020/07/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2020/06/26

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/22

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2020/06/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2020/06/16

重要事件披露

8-K - Current report
2020/06/12

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2020/06/11

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/06/11

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/06/09

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/09

SEC问询函

CORRESP [Cover] - Correspondence
2020/06/08

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2020/05/26

SEC问询函

CORRESP [Cover] - Correspondence
2020/05/22

招股说明书

S-1 - General form for registration of securities under the Securities Act of 1933
2015/02/12

非美公司披露报告